Of the 196 patients in whom JAK2 exon 12 was not tested, PV was excluded with bone marrow investigation in 22, whereas 95 had persistent polycythaemia at the end of follow-up, but only 3 had suppressed Epo. Here, JAK2 is linked to acquired polycythemia vera.